BESREMi is a prescription medicine that is used to treat adults with polycythemia vera
Get notifiedBESREMi is the only FDA-approved treatment indicated for adults with polycythemia vera (PV) that targets the source of the disease.
BESREMi is not chemotherapy, it's an innovative immunotherapy that you take once every 2 weeks to treat PV.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) recommend ropeginterferon alfa-2b-njft (BESREMi) as a preferred first-line cytoreductive treatment option for certain patients with PV.1
BESREMi® can cause serious side effects, including conditions that may cause death or may worsen certain serious diseases you may already have. If symptoms get worse, or become severe and continue, your healthcare provider may tell you to stop taking BESREMi permanently. These symptoms may go away in some people after they stop taking BESREMi.
Mental health problems, including suicide
BESREMi may cause mood or behavior problems that can get worse during treatment or after your last dose, including:
If you develop any of these symptoms, call your healthcare provider immediately.
New or worsening autoimmune problems
BESREMi may cause your immune system to attack healthy cells, leading to conditions such as thyroid disease, increased blood sugar (hyperglycemia), or type 1 diabetes. Call your healthcare provider if you experience:
BESREMi may cause heart problems, including:
You should not take BESREMi if you have:
Do not take BESREMi if you:
Do not take BESREMi if you:
The most common side effects of BESREMi include:
Call your doctor for medical advice about side effects. You may report side effects to PharmaEssentia at 1-800-999-2449 or FDA at 1-800-FDA-1088.
Please see full Prescribing Information including Boxed Warning and Medication Guide for BESREMi.
BESREMi can cause serious side effects, including conditions that may cause death or may worsen certain serious diseases you may already have. If symptoms get worse, or become severe and continue, your healthcare provider may tell you to stop taking BESREMi permanently. These symptoms may go away in some people after they stop taking BESREMi.
BESREMi® may cause you to develop
BESREMi can cause serious side effects that may cause death or may worsen certain serious
We use cookies to offer you a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. Read about how we use cookies by visiting our Privacy Policy.
© 2025 PharmaEssentia Corporation. All rights reserved.
BESREMi, the BESREMi logo, and PharmaEssentia are registered trademarks of PharmaEssentia Corporation, and BESREMi Pen, the BESREMi Pen logo, the PharmaEssentia logo, PharmaEssentia SOURCE, and the PharmaEssentia SOURCE logo are trademarks of PharmaEssentia Corporation.
US-BSRM-2400203 (v2.0) 06/2025